Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

PCOS involves high 11-oxygenated androgens and BPA may worsen it, while IH is not inflammatory.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Vaginal surgeries generally did not significantly change women's sexual quality of life.

Women with hyperandrogenism, especially those with PCOS, are more likely to have psychiatric disorders.

Ashwagandha may improve hormone levels and reduce hair loss in non-classical adrenal hyperplasia.

Atorvastatin is less effective for women with Hashimoto's thyroiditis.

LED therapy can safely and effectively regrow eyebrows in people with frontal fibrosing alopecia.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Spinach-derived thylakoid supplements plus a low-calorie diet helped obese women with polycystic ovary syndrome lose weight and improve their metabolism.

Idiopathic hirsutism is the most common cause of hirsutism in women, followed by PCOS.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Polycystic Ovary Syndrome (PCOS) was found in 3.86% of tenth-grade girls in Guangzhou, China, with higher rates in overweight and obese girls, suggesting diagnosis should focus on hyperandrogenemia.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

AMH levels in adolescents with PCOS are not affected by their weight.

An ovarian tumor can cause high male hormones in postmenopausal women.

Finasteride 5 mg and topical minoxidil 5% effectively increase hair density in women, with finasteride 5 mg having the highest satisfaction.

Recognizing rare hair loss patterns in young females can improve understanding and treatment.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Hair transplants are highly satisfactory for treating female-pattern hair loss.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

The conclusion is that examining the scalp closely and checking for iron levels and thyroid issues is key to understanding chronic hair loss in women.

A mother's iron levels early in pregnancy can influence the DNA makeup of her child, potentially affecting the child's health.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.